Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices.

Daley SR, Koay HF, Dobbs K, Bosticardo M, Wirasinha RC, Pala F, Castagnoli R, Rowe JH, Ott de Bruin LM, Keles S, Lee YN, Somech R, Holland SM, Delmonte OM, Draper D, Maxwell S, Niemela J, Stoddard J, Rosenzweig SD, Poliani PL, Capo V, Villa A, Godfrey DI, Notarangelo LD.

J Allergy Clin Immunol. 2019 Jul;144(1):333-336. doi: 10.1016/j.jaci.2019.03.022. Epub 2019 Apr 30. No abstract available.

PMID:
31053347
2.

Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development.

Ott de Bruin LM, Bosticardo M, Barbieri A, Lin SG, Rowe JH, Poliani PL, Ching K, Eriksson D, Landegren N, Kämpe O, Manis JP, Notarangelo LD.

Blood. 2018 Jul 19;132(3):281-292. doi: 10.1182/blood-2017-12-820985. Epub 2018 May 9.

3.

Patients with CD3G mutations reveal a role for human CD3γ in Treg diversity and suppressive function.

Rowe JH, Delmonte OM, Keles S, Stadinski BD, Dobbs AK, Henderson LA, Yamazaki Y, Allende LM, Bonilla FA, Gonzalez-Granado LI, Celikbilek Celik S, Guner SN, Kapakli H, Yee C, Pai SY, Huseby ES, Reisli I, Regueiro JR, Notarangelo LD.

Blood. 2018 May 24;131(21):2335-2344. doi: 10.1182/blood-2018-02-835561. Epub 2018 Apr 13.

4.

How does the tumor microenvironment play a role in hepatobiliary tumors?

Kamil F, Rowe JH.

J Gastrointest Oncol. 2018 Feb;9(1):180-195. doi: 10.21037/jgo.2017.06.09. Review.

5.

Abnormalities of T-cell receptor repertoire in CD4+ regulatory and conventional T cells in patients with RAG mutations: Implications for autoimmunity.

Rowe JH, Stadinski BD, Henderson LA, Ott de Bruin L, Delmonte O, Lee YN, de la Morena MT, Goyal RK, Hayward A, Huang CH, Kanariou M, King A, Kuijpers TW, Soh JY, Neven B, Walter JE, Huseby ES, Notarangelo LD.

J Allergy Clin Immunol. 2017 Dec;140(6):1739-1743.e7. doi: 10.1016/j.jaci.2017.08.001. Epub 2017 Aug 31. No abstract available.

6.

Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis.

Ghouri YA, Mian I, Rowe JH.

J Carcinog. 2017 May 29;16:1. doi: 10.4103/jcar.JCar_9_16. eCollection 2017. Review.

7.

Geriatrics: Year in review.

Holmes HM, Beck MS, Rowe JH.

J Geriatr Oncol. 2016 Sep;7(5):404-8. doi: 10.1016/j.jgo.2016.06.002. Epub 2016 Jun 14. Review.

PMID:
27313081
8.

Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.

Brauer PM, Pessach IM, Clarke E, Rowe JH, Ott de Bruin L, Lee YN, Dominguez-Brauer C, Comeau AM, Awong G, Felgentreff K, Zhang YH, Bredemeyer A, Al-Herz W, Du L, Ververs F, Kennedy M, Giliani S, Keller G, Sleckman BP, Schatz DG, Bushman FD, Notarangelo LD, Zúñiga-Pflücker JC.

Blood. 2016 Aug 11;128(6):783-93. doi: 10.1182/blood-2015-10-676304. Epub 2016 Jun 14.

9.

Abscisic acid regulates root growth under osmotic stress conditions via an interacting hormonal network with cytokinin, ethylene and auxin.

Rowe JH, Topping JF, Liu J, Lindsey K.

New Phytol. 2016 Jul;211(1):225-39. doi: 10.1111/nph.13882. Epub 2016 Feb 18.

10.

Spatiotemporal modelling of hormonal crosstalk explains the level and patterning of hormones and gene expression in Arabidopsis thaliana wild-type and mutant roots.

Moore S, Zhang X, Mudge A, Rowe JH, Topping JF, Liu J, Lindsey K.

New Phytol. 2015 Sep;207(4):1110-22. doi: 10.1111/nph.13421. Epub 2015 Apr 23.

11.

Commensal microbes drive intestinal inflammation by IL-17-producing CD4+ T cells through ICOSL and OX40L costimulation in the absence of B7-1 and B7-2.

Xin L, Jiang TT, Chaturvedi V, Kinder JM, Ertelt JM, Rowe JH, Steinbrecher KA, Way SS.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10672-7. doi: 10.1073/pnas.1402336111. Epub 2014 Jul 7.

12.

Cutting edge: committed Th1 CD4+ T cell differentiation blocks pregnancy-induced Foxp3 expression with antigen-specific fetal loss.

Xin L, Ertelt JM, Rowe JH, Jiang TT, Kinder JM, Chaturvedi V, Elahi S, Way SS.

J Immunol. 2014 Apr 1;192(7):2970-4. doi: 10.4049/jimmunol.1302678. Epub 2014 Mar 3.

13.

Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Saraf SL, Zhang X, Kanias T, Lash JP, Molokie RE, Oza B, Lai C, Rowe JH, Gowhari M, Hassan J, Desimone J, Machado RF, Gladwin MT, Little JA, Gordeuk VR.

Br J Haematol. 2014 Mar;164(5):729-39. doi: 10.1111/bjh.12690. Epub 2013 Dec 12.

14.

Regulatory T cells and the immune pathogenesis of prenatal infection.

Rowe JH, Ertelt JM, Xin L, Way SS.

Reproduction. 2013 Oct 21;146(6):R191-203. doi: 10.1530/REP-13-0262. Print 2013 Dec. Review.

15.

B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells.

Ertelt JM, Buyukbasaran EZ, Jiang TT, Rowe JH, Xin L, Way SS.

J Leukoc Biol. 2013 Aug;94(2):367-76. doi: 10.1189/jlb.0313118. Epub 2013 Jun 6.

16.

Pregnancy imprints regulatory memory that sustains anergy to fetal antigen.

Rowe JH, Ertelt JM, Xin L, Way SS.

Nature. 2012 Oct 4;490(7418):102-6. doi: 10.1038/nature11462. Epub 2012 Sep 26.

17.

Listeria monocytogenes cytoplasmic entry induces fetal wastage by disrupting maternal Foxp3+ regulatory T cell-sustained fetal tolerance.

Rowe JH, Ertelt JM, Xin L, Way SS.

PLoS Pathog. 2012;8(8):e1002873. doi: 10.1371/journal.ppat.1002873. Epub 2012 Aug 16.

18.

Innate IFN-γ is essential for programmed death ligand-1-mediated T cell stimulation following Listeria monocytogenes infection.

Rowe JH, Ertelt JM, Way SS.

J Immunol. 2012 Jul 15;189(2):876-84. doi: 10.4049/jimmunol.1103227. Epub 2012 Jun 18.

19.

Foxp3(+) regulatory T cells, immune stimulation and host defence against infection.

Rowe JH, Ertelt JM, Way SS.

Immunology. 2012 May;136(1):1-10. doi: 10.1111/j.1365-2567.2011.03551.x. Review.

20.

Selective culling of high avidity antigen-specific CD4+ T cells after virulent Salmonella infection.

Ertelt JM, Johanns TM, Mysz MA, Nanton MR, Rowe JH, Aguilera MN, Way SS.

Immunology. 2011 Dec;134(4):487-97. doi: 10.1111/j.1365-2567.2011.03510.x.

21.

Foxp3+ regulatory T cells impede the priming of protective CD8+ T cells.

Ertelt JM, Rowe JH, Mysz MA, Singh C, Roychowdhury M, Aguilera MN, Way SS.

J Immunol. 2011 Sep 1;187(5):2569-77. doi: 10.4049/jimmunol.1100374. Epub 2011 Aug 1.

22.

Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens.

Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS.

Cell Host Microbe. 2011 Jul 21;10(1):54-64. doi: 10.1016/j.chom.2011.06.005.

23.

Mammalian target of rapamycin as a target in hematological malignancies.

Kelly KR, Rowe JH, Padmanabhan S, Nawrocki ST, Carew JS.

Target Oncol. 2011 Mar;6(1):53-61. doi: 10.1007/s11523-011-0175-8. Epub 2011 Apr 17. Review.

PMID:
21499765
24.

Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection.

Johanns TM, Law CY, Kalekar LA, O'Donnell H, Ertelt JM, Rowe JH, Way SS.

Microbes Infect. 2011 Apr;13(4):322-30. doi: 10.1016/j.micinf.2010.11.004. Epub 2010 Dec 4.

25.

Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection.

Johanns TM, Ertelt JM, Rowe JH, Way SS.

PLoS Pathog. 2010 Aug 12;6(8):e1001043. doi: 10.1371/journal.ppat.1001043.

26.

Interleukin (IL)-21-independent pathogen-specific CD8+ T-cell expansion, and IL-21-dependent suppression of CD4+ T-cell IL-17 production.

Ertelt JM, Johanns TM, Rowe JH, Way SS.

Immunology. 2010 Oct;131(2):183-91. doi: 10.1111/j.1365-2567.2010.03287.x.

27.

Naturally occurring altered peptide ligands control Salmonella-specific CD4+ T cell proliferation, IFN-gamma production, and protective potency.

Johanns TM, Ertelt JM, Lai JC, Rowe JH, Avant RA, Way SS.

J Immunol. 2010 Jan 15;184(2):869-76. doi: 10.4049/jimmunol.0901804. Epub 2009 Dec 21.

28.

Selective priming and expansion of antigen-specific Foxp3- CD4+ T cells during Listeria monocytogenes infection.

Ertelt JM, Rowe JH, Johanns TM, Lai JC, McLachlan JB, Way SS.

J Immunol. 2009 Mar 1;182(5):3032-8. doi: 10.4049/jimmunol.0803402.

29.

Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge.

Rowe JH, Johanns TM, Ertelt JM, Lai JC, Way SS.

Immunology. 2009 Sep;128(1 Suppl):e471-8. doi: 10.1111/j.1365-2567.2008.03001.x. Epub 2008 Dec 17.

30.
31.

The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading.

Gilbert HA, Logan JL, Kagan AR, Friedman HA, Cove JK, Fox M, Muldoon TM, Lonni YW, Rowe JH, Cooper JF, Nussbaum H, Chan P, Rao A, Starr A.

J Urol. 1978 Apr;119(4):488-92.

PMID:
650752
32.

Renal vein leiomyosarcoma.

Gierson ED, Rowe JH.

Am Surg. 1976 Aug;42(8):593-4.

PMID:
942123
33.

Tumor-induced osteomalacia and rickets: a surgically curable syndrome. Report of two cases.

Linovitz RJ, Resnick D, Keissling P, Kondon JJ, Sehler B, Nejdl RJ, Rowe JH, Deftos LJ.

J Bone Joint Surg Am. 1976 Apr;58(3):419-23. No abstract available.

PMID:
177427
34.

Benign mediastinal lipoblastomatosis.

Tabrisky J, Rowe JH, Christine SG, Weinstein ED, Asch M.

J Pediatr Surg. 1974 Jun;9(3):399-401. No abstract available.

PMID:
4843994

Supplemental Content

Support Center